While the tumor cells in our previous study of EBV+ PTCL were of the CD4+CD8-CD56- phenotype, we found that various proportions of EBER+ cells were of the null type (CD45RO-CD3-CD4-, also CD20-) [35]. The gene discussed is NCAM1; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.